$5.60
0.00 (0%)
Indevus Pharmaceuticals (NASDAQ:IDEV.DL)
CAPS Rating:
A biopharmaceutical company engaged in the acquisition, development and commercialization of products to treat urological, gynecological and men's health conditions.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No one has written a Pitch for IDEV.DL yet. Tell us why you think IDEV.DL will outperform or underperform the market.
RSS Headlines
Fool UK
